These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 19577983)

  • 1. Assessment of the SYNTAX score in the Syntax study.
    Serruys PW; Onuma Y; Garg S; Sarno G; van den Brand M; Kappetein AP; Van Dyck N; Mack M; Holmes D; Feldman T; Morice MC; Colombo A; Bass E; Leadley K; Dawkins KD; van Es GA; Morel MA; Mohr FW
    EuroIntervention; 2009 May; 5(1):50-6. PubMed ID: 19577983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility and factors influencing the assessment of the SYNTAX score in the left main Xience study.
    Garot P; Tafflet M; Kumar S; Salvatella N; Darremont O; Jouven X; Carrié D; Lefèvre T; Russu V; Morice MC
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):231-7. PubMed ID: 22511511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years.
    Mohr FW; Rastan AJ; Serruys PW; Kappetein AP; Holmes DR; Pomar JL; Westaby S; Leadley K; Dawkins KD; Mack MJ
    J Thorac Cardiovasc Surg; 2011 Jan; 141(1):130-40. PubMed ID: 21168023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
    Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
    JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy.
    Farooq V; Girasis C; Magro M; Onuma Y; Morel MA; Heo JH; Garcia-Garcia H; Kappetein AP; van den Brand M; Holmes DR; Mack M; Feldman T; Colombo A; Ståhle E; James S; Carrié D; Fournial G; van Es GA; Dawkins KD; Mohr FW; Morice MC; Serruys PW
    EuroIntervention; 2013 Mar; 8(11):1277-85. PubMed ID: 23537954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS).
    Morice MC; Feldman TE; Mack MJ; Ståhle E; Holmes DR; Colombo A; Morel MA; van den Brand M; Serruys PW; Mohr F; Carrié D; Fournial G; James S; Leadley K; Dawkins KD; Kappetein AP
    EuroIntervention; 2011 Oct; 7(6):670-9. PubMed ID: 21959312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.
    Capodanno D; Capranzano P; Di Salvo ME; Caggegi A; Tomasello D; Cincotta G; Miano M; Patané M; Tamburino C; Tolaro S; Patané L; Calafiore AM; Tamburino C
    JACC Cardiovasc Interv; 2009 Aug; 2(8):731-8. PubMed ID: 19695541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility.
    Garg S; Girasis C; Sarno G; Goedhart D; Morel MA; Garcia-Garcia HM; Bressers M; van Es GA; Serruys PW;
    Catheter Cardiovasc Interv; 2010 May; 75(6):946-52. PubMed ID: 20146321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    JACC Cardiovasc Interv; 2010 Jun; 3(6):612-23. PubMed ID: 20630454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trial.
    Zhang YJ; Iqbal J; Campos CM; Klaveren DV; Bourantas CV; Dawkins KD; Banning AP; Escaned J; de Vries T; Morel MA; Farooq V; Onuma Y; Garcia-Garcia HM; Stone GW; Steyerberg EW; Mohr FW; Serruys PW
    J Am Coll Cardiol; 2014 Aug; 64(5):423-32. PubMed ID: 25082573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.
    Farooq V; van Klaveren D; Steyerberg EW; Meliga E; Vergouwe Y; Chieffo A; Kappetein AP; Colombo A; Holmes DR; Mack M; Feldman T; Morice MC; Ståhle E; Onuma Y; Morel MA; Garcia-Garcia HM; van Es GA; Dawkins KD; Mohr FW; Serruys PW
    Lancet; 2013 Feb; 381(9867):639-50. PubMed ID: 23439103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
    Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
    Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
    JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
    Gyöngyösi M; Christ G; Lang I; Kreiner G; Sochor H; Probst P; Neunteufl T; Badr-Eslam R; Winkler S; Nyolczas N; Posa A; Leisch F; Karnik R; Siostrzonek P; Harb S; Heigert M; Zenker G; Benzer W; Bonner G; Kaider A; Glogar D;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):718-27. PubMed ID: 19695539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease.
    Lemesle G; Bonello L; de Labriolle A; Steinberg DH; Roy P; Pinto Slottow TL; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):612-7. PubMed ID: 19309700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bypass Grafting Versus Percutaneous Intervention-Which Is Better in Multivessel Coronary Disease: Lessons From SYNTAX and Beyond.
    Farooq V; Serruys PW
    Prog Cardiovasc Dis; 2015; 58(3):316-34. PubMed ID: 26529569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability and Reproducibility of the SYNTAX Score for Triple-Vessel Disease.
    Basman C; Levine E; Tejpal A; Thampi S; Rashid U; Barry R; Stoffels G; Kliger CA; Coplan N; Patel N; Scheinerman SJ; Singh VP
    Cardiovasc Revasc Med; 2022 Apr; 37():86-89. PubMed ID: 34215557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual SYNTAX score after PCI for triple vessel coronary artery disease: quantifying the adverse effect of incomplete revascularisation.
    Malkin CJ; George V; Ghobrial MS; Krishnan A; Siotia A; Raina T; Morton AC; Gunn J
    EuroIntervention; 2013 Mar; 8(11):1286-95. PubMed ID: 23538157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.
    Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R
    J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.